Metastatic Colorectal Cancer: A Systematic Review of the Value of Current Therapies
Goldstein D, Zeichner S, Bartnik C, Neustadter E, Flowers C. Metastatic Colorectal Cancer: A Systematic Review of the Value of Current Therapies. Clinical Colorectal Cancer 2015, 15: 1-6. PMID: 26541320, PMCID: PMC4744531, DOI: 10.1016/j.clcc.2015.10.002.Peer-Reviewed Original ResearchMeSH KeywordsAngiogenesis InhibitorsAntibodies, MonoclonalAntineoplastic Combined Chemotherapy ProtocolsBevacizumabCamptothecinCetuximabColorectal NeoplasmsCost-Benefit AnalysisDrug CostsFluorouracilHumansIrinotecanLeucovorinNeoplasm MetastasisOrganoplatinum CompoundsOxaliplatinPanitumumabQuality-Adjusted Life YearsTreatment OutcomeUnited StatesConceptsMetastatic colorectal cancerCurrent treatment strategiesTreatment strategiesSystematic reviewIncremental cost-effectiveness ratioUS payer perspectiveHigher drug costsCost-effectiveness ratioCost-effective treatmentCost-effectiveness analysisColorectal cancerCurrent therapiesHigh-value treatmentsPayer perspectiveDrug costsVEGF pathwayUS FoodDrug AdministrationOlder agentsModern agentsSearch criteriaTreatmentPanitumumabCetuximabIrinotecan